Daily Bulletin

Men's Weekly

.

Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study-PR Newswire APAC

MELBOURNE, Australia and SAN FRANCISCO, Oct. 27, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced it has commenced enrolling patients with Multiple System Atrophy (MSA) in its bioMUSE Study in the United States.

BioMUSE is a natural history study that aims to track the progression of...

Read more: Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study-PR Newswire APAC

Business News

What Businesses Need to Know About Intellectual Property Law

Whether you're launching a startup or growing an established brand, understanding intellectual property law is essential. An intellectual property lawyer in Melbourne can guide you through registrat...

Daily Bulletin - avatar Daily Bulletin

Avoiding the Delays – Why Families Hire Registered Migration Agents for Their Parent Visa Application

For many migrants, bringing in their ageing parents to reside with them in Australia is one of the most significant milestones. However, the visa pathway is not always simple. The daunting prerequisit...

Daily Bulletin - avatar Daily Bulletin

The ultimate checklist for launching a digital-first business

If you’re launching a business in 2025, chances are it’s going to be digital-first. Whether you’re running an online store, offering consulting services, or building something entirely new, they all h...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals